Cargando…

Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation

Detalles Bibliográficos
Autores principales:	Iesari, Samuele, Lai, Quirino, Favi, Evaldo, Pisani, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368161/ https://www.ncbi.nlm.nih.gov/pubmed/28332381 http://dx.doi.org/10.3349/ymj.2017.58.3.679

Ejemplares similares

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
por: Binda, Valentina, et al.
Publicado: (2021)

HLA-G14bp ins/del polymorphism and post-transplant weight gain in kidney transplantation: potential implications beyond tolerance
por: Piancatelli, Daniela, et al.
Publicado: (2020)

The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation
por: Lee, Juhan, et al.
Publicado: (2015)

Impact of Donor Age on Clinical Outcomes of Primary Single Kidney Transplantation From Maastricht Category-III Donors After Circulatory Death
por: Favi, Evaldo, et al.
Publicado: (2018)

Allograft Vesicoureteral Reflux after Kidney Transplantation
por: Brescacin, Alessandra, et al.
Publicado: (2022)

Misidentification of preformed anti-HLA-DP antibodies leads to antibody-mediated kidney transplant rejection: a case report
por: Thammanichanond, Duangtawan, et al.
Publicado: (2022)

Spontaneous renal allograft rupture complicated by urinary leakage: case report and review of the literature
por: Favi, Evaldo, et al.
Publicado: (2015)

Outcomes of Patients Receiving a Kidney Transplant or Remaining on the Transplant Waiting List at the Epicentre of the COVID-19 Pandemic in Europe: An Observational Comparative Study
por: Perego, Marta, et al.
Publicado: (2022)

Bortezomib alleviates antibody‐mediated rejection in kidney transplantation by facilitating Atg5 expression
por: Cheng, Hong, et al.
Publicado: (2021)

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
por: Park, Borae Geum, et al.
Publicado: (2019)

Complement Binding Anti-HLA Antibodies and the Survival of Kidney Transplantation
por: Muñoz-Herrera, Claudia M., et al.
Publicado: (2023)

Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection
por: Crespo, Marta, et al.
Publicado: (2021)

Association between anti‐endothelial antigen antibodies and allograft rejection in kidney transplantation
por: Lee, Hyun Ji, et al.
Publicado: (2023)

Imlifidase for the treatment of anti‐HLA antibody‐mediated processes in kidney transplantation
por: Huang, Edmund, et al.
Publicado: (2021)

Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
por: Betjes, Michiel G. H., et al.
Publicado: (2020)

The Pre-Transplant Non-HLA Antibody Burden Associates With the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation
por: Senev, Aleksandar, et al.
Publicado: (2022)

Photopheresis Abates the Anti-HLA Antibody Titer and Renal Failure Progression in Chronic Antibody-Mediated Rejection
por: Gregorini, Marilena, et al.
Publicado: (2021)

End-stage renal disease is a risk factor for complex laparoscopic cholecystectomy in patients waiting for renal transplantation
por: Colozzi, Sara, et al.
Publicado: (2019)

Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
por: Fichtner, Alexander, et al.
Publicado: (2021)

Intra-operative kinetics of anti-HLA antibody in simultaneous liver-kidney transplantation
por: Kueht, M., et al.
Publicado: (2021)

Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2016)

Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
por: Eskandary, Farsad, et al.
Publicado: (2014)

Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation?
por: Chedid, Marcio F., et al.
Publicado: (2019)

Use of Bortezomib as Anti-Humoral Therapy in Kidney Transplantation
por: Yang, Keun Suk, et al.
Publicado: (2014)

Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA
por: Chung, Byung Ha, et al.
Publicado: (2015)

Two Cases of Antibody-Mediated Rejection Following Kidney Transplantation due to HLA-DQB1 Allele-Specific and DQ Alpha Protein-Specific HLA Antibodies
por: Song, Seung Hwan, et al.
Publicado: (2017)

Clinical and Surgical Challenges in Kidney Transplantation: Toward a Personalized Approach?
por: Favi, Evaldo, et al.
Publicado: (2022)

Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats
por: Tajima, Tetsuya, et al.
Publicado: (2023)

New-Onset Diabetes after Kidney Transplantation
por: Ponticelli, Claudio, et al.
Publicado: (2021)

Physical Inactivity: A Modifiable Risk Factor for Morbidity and Mortality in Kidney Transplantation
por: Ponticelli, Claudio, et al.
Publicado: (2021)

Antibody-Mediated Rejection in Kidney Transplantation: A Review
por: Puttarajappa, Chethan, et al.
Publicado: (2012)

Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation
por: Abuazzam, Farah, et al.
Publicado: (2023)

Role of anti-vimentin antibodies in allograft rejection
por: Rose, Marlene L
Publicado: (2013)

Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
por: Morrison, Alexander H., et al.
Publicado: (2019)

Low Incidence of Acute Antibody-Mediated Rejection after HLA Desensitization in Living Donor Kidney Transplant Recipients
por: Fernández Rivera, Constantino, et al.
Publicado: (2022)

Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism
por: Mühlbacher, Jakob, et al.
Publicado: (2021)

Characteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation
por: Jung, Hee-Yeon, et al.
Publicado: (2018)

The Kinetics of Anti-HLA Antibodies in the First Year after Kidney Transplantation: In Whom and When Should They Be Monitored?
por: de Castro, Maria Cristina Ribeiro, et al.
Publicado: (2018)

Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients
por: de Sousa, Marcos Vinicius, et al.
Publicado: (2018)

Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
por: Park, Ji Eun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ud2a2qus5k95efahrt35141lpd